Controlled release dosage forms: From ground to space

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 21, Issue 2, 1996, Pages 87-91

  Colombo, P ^a   Betini, R ^a   Peracchia, M T ^a   Santi, P ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Controlled release; Drug administration routes; Drug delivery; Targeting

Indexed keywords

CONFERENCE PAPER; MEDICAL RESEARCH; SPACE; SUSTAINED RELEASE PREPARATION;

EID: 0030017274     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03190256     Document Type: Conference Paper

References (18)

1. st Spanish-Portuguese Conference on Controlled Drug Delivery, Santiago de Compostela, SP. Abstract book pp. 106.
2. Nagai T., Puisieux F. (1994) : Advances in novel science and technology of drug delivery and targeting. France-Japan Symposium, Kojiri, Kanagawa, J., Abstract book pp. i.
3. Powers Cramer M., Saks S.R. (1994) : Translating safety, efficacy and compliance into economic value for controlled release dosage forms. PharmacoEconomics, 5, 482-504.
4. Santus G., Baker R.W. (1995) : Osmotic drug delivery: a review of the patent literature. J. Controlled Release, 35, 1-21.
5. Conte U., Maggi L., Colombo P., La Manna A. (1993) : Multi-layered hydrophilic matrices as constant release device (Geomatrix® Systems). J. Controlled Release, 26, 39-47.
6. Colombo P. (1993) : Swelling-controlled release in hydrogel matrices for oral route. Advanced Drug Delivery Rev., 11, 37-57.
7. Akiyama Y., Nagakara N., Kosbihara T., Hirai S., Toguchi H. (1995) . In vitro and in vivo evaluation of mucoadhesive microspheres prepared for the gastrointestinal tract using polyglycerol esters of fatty acid and poly(acrylic acid) derivatives. Pharm. Res., 12, 3, 397-405.
8. Green P.G., Flanagan M., Shroot B., Guy R. (1993) : lontophoretic drug delivery. In: Walters K.A., Hadgraft J. (Eds), Pharmaceutical Skin Penetration Enhancement. New York, Marcel Dekker, pp. 311-333.
9. Mitragotri S., Blankschtein D., Langer R. (1995) : Ultrasound-mediated transdermal protein delivery. Science, 269, 850-853.
10. Nagai T., Nishimoto Y., Nambu N., Suzuki Y., Sekinr K. (1984) : Powder dosage form of insulin for nasal administration. J. Controlled Release, 1, 15-22.
11. Heydorn W.E. (1995) : New U.S. agents approved in 1994, Pharm. News, 2, 37.
12. Couvreur P., Dubernet C., Puisieux F. (1995) : Controlled drug delivery with nanoparticles- current possibilities and future trends. Eur. J. Pharm. Biopharm., 41, 2-14.
13. Storm G., Koppenhagen F., Heeremans A., Vingerhoeds M., Crommelin D.J.A. (1995) : Novel development in liposomal delivery of peptides and proteins. J. Controlled Release, 36, 19-24.
14. Vingerhoeds M.H. et al. (1993) : A new application of liposomes in cancer therapy. Immunoliposomes bearing enzymes (immuno-enzymosomes) for site-specific activation of prodrugs. FEBS Lett., 336, 485-490.
15. De Marre A., Soyez H., Schacht E., Shoaibi M.A., Seymur L.W., Rihova B. (1995) : Synthesis and evaluation of macromolecular prodrugs of mitomycin. J. Controlled Release, 36, 87-97.
16. Hashida M., Nishikawa M., Takakura Y (1995) : Hepatic targeting of drugs and proteins by chemical modification. J. Controlled Release, 36, 99-107.
17. Okano T., Kikuchi A., Sakurai Y., Takei Y., Ogata N. (1995) : Temperature responsive poly(N-isopropylacrylamide) as a modulator for alteration of hydrophilic/hydrophobic surface properties to control activation/inactivation of platelets. J. Controlled Release, 36, 125-133.
18. Imamizo M. Yoshida, M., Fujioka K., et al. (1994) : Sustained release of hCG minipellet for newt experiment in space. Biol. Sci. Space, 8, 226-230.